timothy sykes logo

Stock News

Core Scientific’s Surprising Upswing: An In-Depth Look

Jack KelloggAvatar
Written by Jack Kellogg Reviewed by Tim Sykes Fact-checked by Ellis Hobbs
Updated 3/6/2025, 9:18 am ET 3/6/2025, 9:18 am ET | 6 min 6 min read
Core Scientific’s Surprising Upswing: An In-Depth Look Thumbnail

Core Scientific Inc. is likely impacted by the news of its operations amidst bankruptcy and the challenges it faces in scaling its business, which might have contributed to the decline. On Thursday, Core Scientific Inc.’s stocks have been trading down by -13.5 percent.

A Challenging Quarter With Unexpected Stock Behavior

  • Despite a reported Q4 net loss of $0.60 per share, worse than analyst expectations, Core Scientific shares rose over 10% in after-hours trading, a stark contrast to the challenging data presented.
  • Revenue fell significantly to $94.9M, missing the consensus estimate of $98.8M. Yet, this didn’t deter investors’ optimism evidenced by the surge in after-hours trading.
  • Bitcoin production in February took a hit, with mined coins dropping to 215 from January’s 256, and a slight dip in the company’s total rated mining capacity.
  • The firm reported Q4 revenues that were lower than anticipated, signaling challenges in meeting the market’s bottom-line goals.

Candlestick Chart

Live Update At 09:18:08 EST: On Thursday, March 06, 2025 Core Scientific Inc. stock [NASDAQ: CORZ] is trending down by -13.5%! Discover the key drivers behind this movement as well as our expert analysis in the detailed breakdown below.

Understanding Core Scientific’s Financial Landscape

“Be patient, don’t force trades, and let the perfect setups come to you.” is vital advice for anyone navigating the complex world of trading. As millionaire penny stock trader and teacher Tim Sykes says, “Be patient, don’t force trades, and let the perfect setups come to you.” This wisdom emphasizes the importance of waiting for the right opportunities instead of impulsively making decisions that could lead to unnecessary risks. By incorporating patience into their strategies, traders can improve their outcomes and achieve more consistent success.

Core Scientific Inc. recently faced an earnings release that spoke volumes about its current financial standing. The backdrop for this is crucial: a reported Q4 net loss of $0.60 per share, surpassing last year’s result and well below analyst expectations of a $0.09 loss. Adding to the financial puzzle was a decline in revenue from last year’s $141.9M to $94.9M—significantly missing the $98.8M figure analysts had hoped for. Yet in an intriguing turn, stock activity showed unexpected buoyancy, leaving many to wonder about the ripple effects for stakeholders.

More Breaking News

On the broader financial canvas, the company’s profitability margins paint a complex picture. The EBIT margin, standing at -257.1%, together with other margins dipping into the negatives, portray a tale of operational struggles. Yet among these statistics, a ray of hope emerges with a gross margin of 23.7%, offering a glimmer amidst the cloudy data.

A Dive Into Company Performance and Market Impact

The stock market’s response to Core Scientific’s outcomes is as much a reflection of market psychology as it is of financial realities. Despite an arduous earnings report, indicative of struggles, stock prices jumped over 10% in after-hours trading. Many investors banking on the long game might view this as a chance to lean back and watch the unfolding narrative, but others are left scratching their heads about the fuel driving such upbeat sentiment.

Revenues showcased a contraction to $94.9M, reminiscing days gone by when revenues held stronger footing. Yet, perseverance in the face of adversity might be part of the narrative that’s driving investor loyalty—a testament to the potential they still see in the company. The slight downturn in Bitcoin production and the overall rated capacity add layers to the operational dimensions influencing financial outcomes.

Amidst these financial waves, one cannot overlook the market dynamics at play. Investors often look beyond numbers, weighing the company’s potential for transformation against immediate setbacks. It’s these forward-thinking investors and market insiders who may be driving the stock’s surprisingly positive surge.

Key Financial Insights and Predictions

The numbers often tell a story filled with nuance, and Core Scientific’s latest financial metrics underscore just that. From operating cash flow changes to the noteworthy tech purchases and sales adjustments, each financial maneuver reflects the company’s strategic decisions. With a challenging payday staring them in the face due to the last quarter’s outcomes, the boardroom decisions in the coming months will prove pivotal.

Operationally, expenses have been etched higher, driven by elements like general administrative costs and research expenses. Yet, despite these tangible rises in expenses, traders pushing the stock higher suggest anticipation of better days. This group likely harbors the belief that the company’s strategic endeavors will gradually steer it toward a more prosperous path—a feeling that may well have influenced the recent surge in share prices. As millionaire penny stock trader and teacher Tim Sykes says, “Embrace the journey, the ups and downs; each mistake is a lesson to improve your strategy.”

Core Scientific experienced a dynamic trading period suggesting a volatile journey. Yet, trader sentiment during these fluctuations has painted a tale of mixed results, revealing the importance of a diversified financial plan going forward.

Bitcoin mining, a core business pillar for Core Scientific, has experienced ebb and flow. February’s decline from January may flag a short-term hiccup, but the company’s ability to strategize and recalibrate can rejuvenate its production pipeline. Traders, as seen in recent stock behavior, continue to show confidence in the company’s strategies.

The paths laid out by these challenges and trader reactions provide pivotal moments that could either enhance or deter future prospects. Trader patience and market adaptability will thus remain key in navigating these unfolding chapters.

This is stock news, not investment advice. Timothy Sykes News delivers real-time stock market news focused on key catalysts driving short-term price movements. Our content is tailored for active traders and investors seeking to capitalize on rapid price fluctuations, particularly in volatile sectors like penny stocks. Readers come to us for detailed coverage on earnings reports, mergers, FDA approvals, new contracts, and unusual trading volumes that can trigger significant short-term price action. Some users utilize our news to explain sudden stock movements, while others rely on it for diligent research into potential investment opportunities.

Dive deeper into the world of trading with Timothy Sykes, renowned for his expertise in penny stocks. Explore his top picks and discover the strategies that have propelled him to success with these articles:

Once you’ve got some stocks on watch, elevate your trading game with StocksToTrade the ultimate platform for traders. With specialized tools for swing and day trading, StocksToTrade will guide you through the market’s twists and turns.
Dig into StocksToTrade’s watchlists here:

How much has this post helped you?

(0 votes, average: 0 out of 5)
Leave a reply
Author card Timothy Sykes picture

Jack Kellogg

He teaches webinars on Tim Sykes’ Trading Challenge He became Tim’s youngest millionaire student in 2020. Now he’s second on the Trading Challenge leaderboard with $12.9 million in career earnings. He’s a master of the 7-Step Pennystocking Framework. Jack is one of a rare breed of traders to profitably trade the entire penny stock framework.
Read More

* Results are not typical and will vary from person to person. Making money trading stocks takes time, dedication, and hard work. There are inherent risks involved with investing in the stock market, including the loss of your investment. Past performance in the market is not indicative of future results. Any investment is at your own risk. See Terms of Service here

The available research on day trading suggests that most active traders lose money. Fees and overtrading are major contributors to these losses.

A 2000 study called “Trading is Hazardous to Your Wealth: The Common Stock Investment Performance of Individual Investors” evaluated 66,465 U.S. households that held stocks from 1991 to 1996. The households that traded most averaged an 11.4% annual return during a period where the overall market gained 17.9%. These lower returns were attributed to overconfidence.

A 2014 paper (revised 2019) titled “Learning Fast or Slow?” analyzed the complete transaction history of the Taiwan Stock Exchange between 1992 and 2006. It looked at the ongoing performance of day traders in this sample, and found that 97% of day traders can expect to lose money from trading, and more than 90% of all day trading volume can be traced to investors who predictably lose money. Additionally, it tied the behavior of gamblers and drivers who get more speeding tickets to overtrading, and cited studies showing that legalized gambling has an inverse effect on trading volume.

A 2019 research study (revised 2020) called “Day Trading for a Living?” observed 19,646 Brazilian futures contract traders who started day trading from 2013 to 2015, and recorded two years of their trading activity. The study authors found that 97% of traders with more than 300 days actively trading lost money, and only 1.1% earned more than the Brazilian minimum wage ($16 USD per day). They hypothesized that the greater returns shown in previous studies did not differentiate between frequent day traders and those who traded rarely, and that more frequent trading activity decreases the chance of profitability.

These studies show the wide variance of the available data on day trading profitability. One thing that seems clear from the research is that most day traders lose money .

Millionaire Media 66 W Flagler St. Ste. 900 Miami, FL 33130 United States (888) 878-3621 This is for information purposes only as Millionaire Media LLC nor Timothy Sykes is registered as a securities broker-dealer or an investment adviser. No information herein is intended as securities brokerage, investment, tax, accounting or legal advice, as an offer or solicitation of an offer to sell or buy, or as an endorsement, recommendation or sponsorship of any company, security or fund. Millionaire Media LLC and Timothy Sykes cannot and does not assess, verify or guarantee the adequacy, accuracy or completeness of any information, the suitability or profitability of any particular investment, or the potential value of any investment or informational source. The reader bears responsibility for his/her own investment research and decisions, should seek the advice of a qualified securities professional before making any investment, and investigate and fully understand any and all risks before investing. Millionaire Media LLC and Timothy Sykes in no way warrants the solvency, financial condition, or investment advisability of any of the securities mentioned in communications or websites. In addition, Millionaire Media LLC and Timothy Sykes accepts no liability whatsoever for any direct or consequential loss arising from any use of this information. This information is not intended to be used as the sole basis of any investment decision, nor should it be construed as advice designed to meet the investment needs of any particular investor. Past performance is not necessarily indicative of future returns.

Citations for Disclaimer

Barber, Brad M. and Odean, Terrance, Trading is Hazardous to Your Wealth: The Common Stock Investment Performance of Individual Investors. Available at SSRN: “Day Trading for a Living?”

Barber, Brad M. and Lee, Yi-Tsung and Liu, Yu-Jane and Odean, Terrance and Zhang, Ke, Learning Fast or Slow? (May 28, 2019). Forthcoming: Review of Asset Pricing Studies, Available at SSRN: “https://ssrn.com/abstract=2535636”

Chague, Fernando and De-Losso, Rodrigo and Giovannetti, Bruno, Day Trading for a Living? (June 11, 2020). Available at SSRN: “https://ssrn.com/abstract=3423101”